Development of ciclopirox nail lacquer with enhanced permeation and retention

Raj Kumar Thapa1, Ju Yeon Choi1, Toe Gyung Go1

  • 1College of Pharmacy, Yeungnam University, 214-1 Dae-dong, Gyeongsan, 712-749, South Korea.

Insights

This study developed a new nail lacquer to improve ciclopirox penetration for treating fungal nail infections (onychomycosis). The enhanced formulation showed better ciclopirox retention in nails compared to existing products.

Area of Science:

  • Pharmaceutical Sciences
  • Dermatology
  • Mycology

Background:

  • Onychomycosis is a common fungal nail infection, particularly affecting athletes and the elderly.
  • Topical ciclopirox is approved for onychomycosis treatment but suffers from poor nail penetration.
  • Enhanced drug delivery is crucial for effective topical onychomycosis therapy.

Purpose of the Study:

  • To develop an improved nail lacquer formulation for enhanced ciclopirox permeation and retention.
  • To identify optimal solvents, alkalizing agents, and permeation enhancers for ciclopirox delivery.
  • To evaluate the efficacy of the new formulation against marketed products.

Main Methods:

  • Screening various solvents, alkalizing agents, and permeation enhancers.
  • Assessing ciclopirox permeation through bovine hooves.
  • Measuring ciclopirox retention in human nail clippings.
  • Comparing the developed lacquer with a marketed product.

Main Results:

  • Isopropyl alcohol, potassium hydroxide, and urea significantly improved ciclopirox permeation and retention.
  • The developed nail lacquer demonstrated higher flux rates compared to standard topical applications.
  • Enhanced retention of ciclopirox was observed in human nail clippings from the new formulation.

Conclusions:

  • The novel nail lacquer formulation effectively enhances ciclopirox permeation and retention.
  • This formulation shows potential as a more effective treatment for onychomycosis.
  • Further clinical studies are warranted to confirm efficacy in human patients.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
297
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
299
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
191
Factors Influencing Drug Absorption: Physicochemical Parameters01:22

Factors Influencing Drug Absorption: Physicochemical Parameters

The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
1.2K
Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
103
Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
138